About Genesis Research
Genesis Research is a Healthcare company based in Hoboken (United States) founded in 2009, and was acquired by GHO Capital Partners in October 2021. Research support is provided to the life science industry. Genesis Research has completed 2 acquisitions, including EvidScience and Market Access Transformation. Its chief executive, as recorded, is Frank A Corvino. Genesis Research offers products and services including Real-World Evidence Services and HEOR Consulting. Its focus areas include Medical Research Labs. Its legal entity is Genesis Research Group.
Company details
Genesis Research was established in 2009 in Hoboken, United States, as a research lab focused on the life science sector. Services are delivered to support industry needs through scientific research and analysis. Operations are centered in Hoboken, with oversight by CEO Frank A. Corvino. Assistance is extended to clients in drug development, market analysis, and related areas within the life sciences field.
- Headquarters Hoboken, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website genesisrg.com
- Social LinkedIn X Instagram
- Acquired by GHO Capital Partners (Oct 2021)
- Legal Name Genesis Research Group
- InvestorsRallyday Partners
& 1 more
- Investments & AcquisitionsEvidScience
& 1 more
- Acquired byGHO Capital Partners
(Oct 2021)
Products & Services of Genesis Research
Genesis Research offers a comprehensive portfolio of products and services, including Real-World Evidence Services and HEOR Consulting.
Real-world evidence services are offered for healthcare research and evidence generation using data-agnostic approaches.
Health economics and outcomes research consulting is provided to assist with market access and pricing strategies.
Funding Insights of Genesis Research
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Genesis Research with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2020 | Private Equity Round | – | Rallyday Partners | – |
2 investors in total: 2 institutional.
Investors in Genesis Research
Genesis Research has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Rallyday Partners and GHO Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are made to empower growing companies. | rallydaypartners.com | Denver, United States | ||
Specialist healthcare investment advisory services are provided by GHO Capital. | ghocapital.com | London, United Kingdom |
Investor details for Genesis Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Genesis Research
89 people are tracked at Genesis Research (44 in leadership, 45 in team).
| Name | Role | Group |
|---|---|---|
Frank A Corvino | CEO | Leadership |
Andy S. | Executive Director, RWE And Data Strategy | Leadership |
Jeffrey Anderson | Director, Epidemiology | Leadership |
Daksh Gulati | Director Access And Pricing | Leadership |
Nicole Cameron | Fp&a Director | Leadership |
Richard Chumbley | Marketing Director | Leadership |
Andrea Barthel | Director | Leadership |
McClain Monica | Director, Epidemiology | Leadership |
Joanna MacEwan | Senior Director, Evidence Strategy | Leadership |
Michael Livingstone | Chief People Officer | Leadership |
Diana Amari | Executive Director, Head Of Project Operations & Initiatives | Leadership |
Allison Keshishian | Director, Evidence Strategy | Leadership |
Alexandra Sosinsky | Senior Director, Pharmacoepidemiology & Safety | Leadership |
Aaron Crowley | Associate Director | Leadership |
Alex Graham | Vp, Global Business Development And Client Strategy | Leadership |
Dwayne Haynes | Vice President Of Global Business Development | Leadership |
Darrin Benjumea | Director, Evidence Strategy | Leadership |
Sarah Ayton | Associate Director, Analytics | Leadership |
Amie Devlin | Associate Director, Evidence Strategy | Leadership |
Angie Greenlees | Associate Director - Global Stakeholder Management | Leadership |
69 more people are available in the full profile.
Complete people profiles for Genesis Research
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genesis Research
Genesis Research has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include EvidScience and Market Access Transformation.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Online platform to find life sciences companies payers | marketaccesstransformation.com | Short Hills, United States | 2015 | May 2022 | •••• | |
Developer an ML platform for generating insights by analyzing pharma literature | evidscience.com | El Segundo, United States | 2016 | Jan 2021 | •••• |
Complete acquisition details for Genesis Research
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Genesis Research
5 dated milestones of Genesis Research across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Genesis Research is founded.
- Funding First funding round.
- Acquisition Acquires EvidScience.
- Exit Acquired by GHO Capital Partners.
- Acquisition Acquires Market Access Transformation.
Web traffic of Genesis Research
The website of Genesis Research (genesisrg.com) receives about 5.1K visits a month.
- Monthly visits5.1K
▲ 34.2% vs previous month
Websites whose visitors overlap most with Genesis Research. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| scynexis.com | 100% | 6.5K | #4,483,848 | View details | |
| apcerls.com | 100% | #3,323,878 | View details | ||
asembiasummit.com | asembiasummit.com | 92% | #4,884,219 | – | |
elevartx.com | elevartx.com | 83% | #2,265,362 | – |
Top companies in Clinical Trials & Research Tech
3 companies that operate in the same segment as Genesis Research (Clinical Trials & Research Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 619.8 M | 252 | ||
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | 22 | ||
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | 25 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genesis Research
Genesis Research was founded in 2009 and raised its 1st funding round 11 years after it was founded.
Genesis Research is headquartered in Hoboken, United States. It is registered at Hoboken, New Jersey, United States.
Frank A Corvino is the CEO of Genesis Research, as recorded in our data.
Genesis Research was established in 2009 in Hoboken, United States, as a research lab focused on the life science sector. Services are delivered to support industry needs through scientific research and analysis. Operations are centered in Hoboken, with oversight by CEO Frank A. Corvino. Assistance is extended to clients in drug development, market analysis, and related areas within the life sciences field.
Genesis Research offers Real-World Evidence Services and HEOR Consulting.
Genesis Research has made 2 acquisitions, including EvidScience, and Market Access Transformation.
Genesis Research has 2 investors. Key investors include Rallyday Partners, and GHO Capital.
Genesis Research operates through Genesis Research Group.
Yes. Genesis Research was acquired by GHO Capital Partners in October 2021.